M. Nekulová

Prediction of ovarian cancer prognosis and response to chemotherapy by a serum-based multiparametric biomarker panel

E. Diamandis, R. Wolfert, I. Simon, 2008, British Journal of Cancer.

Three-year follow-up of carcinoembryonal antigen levels in the serum of patients with breast cancer.

M. Nekulová, A. Kočent, J. Hlávková, 1984, Neoplasma.

Significance of pre-treatment immunological parameters in colorectal cancer patients with unresectable metastases to the liver.

J. Kovarik, M. Sheard, J. Zaloudik, 1999, Hepato-gastroenterology.

Relation between dose, plasma concentration and toxicity in a phase I trial using high dose intermittent administration of an alkylating agent, diacetyldianhydrogalactitol (DADAG)

P. Kovacs, G. Ujj, Z. Mechl, 2004, Cancer Chemotherapy and Pharmacology.

Phase II study of aclarubicin in patients with breast cancer previously untreated with adriamycin

Z. Mechl, S. Kerpel-Fronius, I. Hindy, 1987, European journal of haematology. Supplementum.